Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model-Reference-Cited by-同舟云学术

Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model

Published:2021-11-10 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sawa Mariko¹,Overk Cassia¹,Becker Ann¹,Derse Dominique¹,Albay Ricardo¹,Weldy Kim¹,Salehi Ahmad²,Beach Thomas G.³,Doran Eric⁴,Head Elizabeth⁵,Yu Y. Eugene⁶,Mobley William C¹

Affiliation:

1. Department of Neurosciences University of California San Diego La Jolla California USA

2. Department of Psychiatry and Behavioral Sciences Stanford University Stanford California USA

3. Brain and Body Donation Program Banner Sun Health Research Institute Sun City Arizona USA

4. Department of Pediatrics University of California Irvine California USA

5. Department of Pathology & Laboratory Medicine University of California Irvine California USA

6. The Children's Guild Foundation Down Syndrome Research Program, Genetics and Genomics Program Roswell Park Comprehensive Cancer Center Buffalo New York USA

Funder

National Institutes of Health

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12463

Reference175 articles.

1. Further understanding the connection between Alzheimer's disease and Down syndrome

2. Epidemiology of Down syndrome in 118,265 consecutive births

3. Estimation of the number of people with Down syndrome in the United States

4. Current Estimate of Down Syndrome Population Prevalence in the United States

5. Down syndrome

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome;Aging;2023-12-12

2. Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology;2023-12-11

3. Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome;Biological Research;2023-12-09

4. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease;Neurobiology of Disease;2023-11

5. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome;Alzheimer's & Dementia;2023-10-19